News
For the first time, the G20 will meet on African soil - at a moment when demands to reshape the global economy are intensifying. Climate instability, biodiversity loss, the rising cost of capital, and ...
Use our checklist to ensure you are ready for your journey to the UK and fully prepared for your stay in London. Before you arrive If you are unsure if you need a visa, please check your visa status ...
An annual event dedicated to recognising and embracing the diverse backgrounds of students, staff, and faculty.
UCL has been named the ninth best university in the 2026 QS World University Rankings, the third year in a row the university ...
Drop in at the UCL Art Museum between 11 and 12 for a short guided visit (approx. 15 minutes) led by one of the museum's ...
What if a single hormone could control appetite in two entirely different ways? Professor Stefan Trapp of University College London reveals how GLP-1’s dual role in the brain and gut could transform ...
Dr Edwin Jabbari, an Academic Neurologist specialising in Movement Disorders in the Department of Clinical and Movement Neurosciences, has received an MRC Clinician Scientist Fellowship worth £2.3 ...
1st in the UK and 5th globally in the QS Sustainability Rankings, UCL’s achievements are driven by innovative initiatives like PEARL, its first net-zero carbon building. University College London (UCL ...
A world-class education in one of the world’s most global cities W hy Choose UCL Geography? | Our Courses | Support for International Students | Life in London | How to Apply | Ready to Join Us?. UCL ...
Astronomers at UCL and the University of Warwick, as part of a global collaboration including partners in Chile, USA and Europe, have discovered the smallest known star to host a transiting giant ...
Meeting with Secretary of Agriculture, Julio Berdegué and Professor Mazzucato. Mariana Mazzucato, Professor in the Economics of Innovation and Public Value at University College London, Founding ...
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results